Role of the IL-15 system in ischemia stroke pathophysiology and therapeutic strategies

J Formos Med Assoc. 2019 Jul;118(7):1080-1082. doi: 10.1016/j.jfma.2019.02.013. Epub 2019 Mar 16.

Authors

Gilbert Aaron Lee¹, Nan-Shih Liao²

Affiliations

¹ Department of Medical Research, Taipei Medical University Hospital, Taipei, Taiwan. Electronic address: 154101@h.tmu.edu.tw.
² Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan. Electronic address: mbfelix@imb.sinica.edu.tw.

PMID: 30890295
DOI: 10.1016/j.jfma.2019.02.013

No abstract available

MeSH terms

Animals
Astrocytes / immunology*
Brain Ischemia* / metabolism
Brain Ischemia* / physiopathology
Brain Ischemia* / therapy
CD8-Positive T-Lymphocytes / immunology*
Cerebral Revascularization / methods
Glial Fibrillary Acidic Protein / metabolism
Interleukin-15* / antagonists & inhibitors
Interleukin-15* / immunology
Killer Cells, Natural / immunology*
Lymphocyte Activation / immunology
Mice
Models, Animal
Reperfusion Injury / immunology
Stroke* / metabolism
Stroke* / physiopathology
Stroke* / therapy

Substances

Glial Fibrillary Acidic Protein
Interleukin-15
glial fibrillary astrocytic protein, mouse